secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTELLIGENT BIO SOLUTIONS INC. (INBS)
CIK:        0001725430
Form:       8-K
Filed at:   2025-09-26T23:59:59+00:00
Accession:  0001493152-25-015068
Event type: regulatory
Sentiment:  neutral
Materiality: 0.55
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Intelligent Bio Solutions updates FDA 510(k) timeline; clearance expected H2 2026
--------------------------------------------------------------------------------

- Will commence clinical studies before year-end to gather additional data for FDA 510(k) resubmission for codeine fingerprint test.
- Anticipates FDA 510(k) clearance for opiate codeine use in the second half of 2026.
- Drug screening system adopted by over 450 accounts in 24 countries with 18 distribution partners.
- Currently marketed outside U.S. and for forensic use only; FDA clearance would open broader U.S. commercial entry.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1725430/000149315225015068/0001493152-25-015068-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1725430/000149315225015068/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-015068

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer